(Q69368341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

1 reference

S De Wit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

D Weerts

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

H Goossens

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

N Clumeck

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

language of work or name

English

0 references

publication date

1 April 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

746-748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

8641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

Current concepts. Treatment of infections associated with human immunodeficiency virus

1 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Cryptococcal meningitis and fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Treatment of systemic fungal infections: recent progress and current problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Hepatic reactions associated with ketoconazole in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Ketoconazole Blocks Adrenal Steroid Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Azole antifungal drugs: old and new.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Azole antifungal agents: emphasis on new triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

Fluconazole and testosterone: in vivo and in vitro studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992572-5

7 January 2021

10.1016/S0140-6736(89)92572-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2564563%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference